Clinical trial data validate the C-peptide estimate model in type 1 diabetes

Diabetologia. 2020 Apr;63(4):885-886. doi: 10.1007/s00125-020-05088-6. Epub 2020 Jan 26.

John M Wentworth^{1

2

3}, Naiara G Bediaga⁴, Stephen E Gitelman⁵, Carmela Evans-Molina⁶, Peter A Gottlieb⁷, Peter G Colman^{8

9}, Michael J Haller¹⁰, Leonard C Harrison⁴

¹ Royal Melbourne Hospital Department of Diabetes and Endocrinology, Parkville, VIC, Australia. [email protected].
² Royal Melbourne Hospital Department of Medicine, University of Melbourne, Parkville, VIC, Australia. [email protected].
³ Department of Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia. [email protected].
⁴ Department of Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.
⁵ Pediatric Diabetes, University of California at San Francisco, San Francisco, CA, USA.
⁶ Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN, USA.
⁷ Barbara Davis Center for Childhood Diabetes, University of Colorado, Aurora, CO, USA.
⁸ Royal Melbourne Hospital Department of Diabetes and Endocrinology, Parkville, VIC, Australia.
⁹ Royal Melbourne Hospital Department of Medicine, University of Melbourne, Parkville, VIC, Australia.
¹⁰ Pediatric Endocrinology, University of Florida, Gainesville, FL, USA.

No abstract available

Publication types